Skip to main content

Table 2 Clinical characteristics of the patients in the events investigated.

From: Ventilator associated pneumonia: comparison between quantitative and qualitative cultures of tracheal aspirates

Parameter

Total evaluations (%)

Evaluations in VAP group (%)

Number of evaluations

219 (100%)

38 (100%)

Tracheostomy (n [%])

59 (26.9%)

10 (26.3%)

Atelectasisa (n [%])

13 (6.0%)

6 (15.7%)

Lung edemaa (n [%])

35 (16.0%)

9 (23.6%)

Lung contusiona (n [%])

6 (2.7%)

1 (2.6%)

Pleural effusiona (n [%])

21 (9,5%)

8 (21.0%)

Previous lung disease (n [%])

30 (13.6%)

6 (15.7%)

COPD

16 (7.3%)

3 (7.8%)

Cancer

11 (5.0%)

2 (5.2%)

Asthma

2 (0.9%)

1 (2.6%)

Pulmonary fibrosis

1 (0.4%)

None

Broncoaspiration (n [%])

12 (5.4%)

3 (7.8%)

Sepsis (n [%])

46 (21.0%)

14 (36.8%)

ARDS (n [%])

12 (5,4%)

3 (7.8%)

Renal failure (n [%]; creatinine >2.0 mg/dl)

91 (41.5%)

20 (52.6%)

Diabetes (n [%])

35 (16.0%)

5 (13.1%)

Chemotherapy (n [%])

13 (6.0%)

2 (5.2%)

Radiotherapy (n [%])

2 (0.9%)

None

Immunossupressants drugs (n [%])

5 (2.2%)

1 (2.6%)

AIDS (n [%])

3 (1.3%)

None

Renal transplantation (n [%])

5 (2.2%)

1 (2.6%)

Abdominal surgery (n [%])

32 (14.6%)

7 (18.4%)

Multiple trauma (n [%])

21 (9.5%)

3 (7.9%)

Neuromuscular blocking agents (n [%])

7 (3.1%)

7 (18.4%)

Central venous line (n [%])

215 (98.0%)

38 (100%)

Intracranial pressure monitoring (n [%])

20 (9.1%)

1 (2.6%)

  1. aAccording to clinical judgement. ARDS, acute respiratory distress syndrome; COPD, chronic obstructive pulmonary disease; VAP, ventilator-associated pneumonia.